Eosinophil cationic protein (ECP) is processed during secretion

Area of Science:

• Immunology
• Allergy Research
• Cell Biology

Background:

• Eosinophils are key inflammatory cells in allergic diseases like asthma and rhinitis.
• Eosinophil cationic protein (ECP) is a granule protein released upon eosinophil activation.
• ECP's cytotoxic potential and molecular variants are central to its role in allergic inflammation.

Purpose of the Study:

• To investigate the molecular alterations of ECP during secretion from activated eosinophils.
• To test the hypothesis that stored, non-cytotoxic ECP is converted into cytotoxic forms upon release.
• To characterize the specific ECP variants secreted under different stimulation conditions.

Main Methods:

• Purification of eosinophils from allergic and healthy individuals.
• Stimulation of eosinophils with cytokines (IL-5, GM-CSF) or particles.
• Measurement of ECP concentration using fluoroenzyme immunoassay.
• Analysis of ECP heterogeneity and molecular mass via affinity capture and MALDI-TOF mass spectrometry.

Main Results:

• Unstimulated eosinophils contained 10 ECP variants (16.1–17.7 kDa).
• Particle stimulation primarily released two variants (16.1 and 16.3 kDa).
• Cytokine stimulation yielded a distinct ECP secretion profile, with modifications partly due to N-linked glycosylation differences.

Conclusions:

• Eosinophil cationic protein secretion involves significant protein modification.
• Released ECP variants acquire molecular masses consistent with cytotoxic forms.
• These findings elucidate ECP's transformation during allergic inflammatory responses.